Literature DB >> 21928406

Neoplastic pericardial effusion.

Marwan M Refaat1, William E Katz.   

Abstract

Neoplastic pericardial effusion is a serious and common clinical disorder encountered by cardiologists, cardiothoracic surgeons, oncologists, and radiation oncologists. It may develop from direct extension or metastatic spread of the underlying malignancy, from an opportunistic infection, or from a complication of radiation therapy or chemotherapeutic toxicity. The clinical presentation varies, and the patient may be hemodynamically unstable in the setting of constrictive pericarditis and cardiac tamponade. The management depends on the patient's prognosis and varies from pericardiocentesis, sclerotherapy, and balloon pericardiotomy to cardiothoracic surgery. Patients with neoplastic pericardial effusion face a grave prognosis, as their malignancy is usually more advanced. This review article discusses the epidemiology and etiology, pathophysiology, clinical presentation, diagnosis, management, and prognosis of neoplastic pericardial effusion.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21928406      PMCID: PMC6652358          DOI: 10.1002/clc.20936

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  40 in total

1.  Correlation between clinical and Doppler echocardiographic findings in patients with moderate and large pericardial effusion: implications for the diagnosis of cardiac tamponade.

Authors:  J Mercé; J Sagristà-Sauleda; G Permanyer-Miralda; A Evangelista; J Soler-Soler
Journal:  Am Heart J       Date:  1999-10       Impact factor: 4.749

Review 2.  Management of pericardial effusion.

Authors:  J Soler-Soler; J Sagristà-Sauleda; G Permanyer-Miralda
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

3.  RELATIONSHIP OF PERICARDIAL TO PLEURAL PRESSURE DURING QUIET RESPIRATION AND CARDIAC TAMPONADE.

Authors:  B C MORGAN; W G GUNTHEROTH; D H DILLARD
Journal:  Circ Res       Date:  1965-06       Impact factor: 17.367

4.  Metastatic cancer to the heart. Review of the literature and report of 127 cases.

Authors:  S M HANFLING
Journal:  Circulation       Date:  1960-09       Impact factor: 29.690

5.  Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology.

Authors:  Bernhard Maisch; Petar M Seferović; Arsen D Ristić; Raimund Erbel; Reiner Rienmüller; Yehuda Adler; Witold Z Tomkowski; Gaetano Thiene; Magdi H Yacoub
Journal:  Eur Heart J       Date:  2004-04       Impact factor: 29.983

6.  Studies in experimental pericardial tamponade; effects on intravascular pressures and cardiac output.

Authors:  J METCALFE; J W WOODBURY; V RICHARDS; C S BURWELL
Journal:  Circulation       Date:  1952-04       Impact factor: 29.690

7.  Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years.

Authors:  Teresa S M Tsang; Maurice Enriquez-Sarano; William K Freeman; Marion E Barnes; Lawrence J Sinak; Bernard J Gersh; Kent R Bailey; James B Seward
Journal:  Mayo Clin Proc       Date:  2002-05       Impact factor: 7.616

8.  Pericardoscopy for primary management of pericardial effusion in cancer patients.

Authors:  H L Porte; T J Janecki-Delebecq; L Finzi; D G Métois; A Millaire; A J Wurtz
Journal:  Eur J Cardiothorac Surg       Date:  1999-09       Impact factor: 4.191

9.  Quantitative Echocardiographic Assessment in Pericardial Disease.

Authors:  Afzal Ur Rehman; Holly L. Hancock
Journal:  Echocardiography       Date:  1997-03       Impact factor: 1.724

10.  Differentiation of constrictive pericarditis from restrictive cardiomyopathy using mitral annular velocity by tissue Doppler echocardiography.

Authors:  Jong-Won Ha; Steve R Ommen; A Jamil Tajik; Marion E Barnes; Naser M Ammash; Morie A Gertz; James B Seward; Jae K Oh
Journal:  Am J Cardiol       Date:  2004-08-01       Impact factor: 2.778

View more
  21 in total

1.  Sudden death due to cardiac tamponade from malignant pericardial involvement by metastatic lung cancer.

Authors:  Robert Cassady; Joseph A Prahlow
Journal:  Forensic Sci Med Pathol       Date:  2014-10-19       Impact factor: 2.007

2.  The importance of an ECG: back to basics.

Authors:  Golaleh Haidari; Kirsty Gray; Senthil Kirubakaran
Journal:  BMJ Case Rep       Date:  2012-11-28

3.  Pericardiocentesis versus pericardiotomy for malignant pericardial effusion: a retrospective comparison.

Authors:  C Labbé; L Tremblay; Y Lacasse
Journal:  Curr Oncol       Date:  2015-12       Impact factor: 3.677

Review 4.  Pericardial Disease Associated with Malignancy.

Authors:  Ryan Schusler; Shari L Meyerson
Journal:  Curr Cardiol Rep       Date:  2018-08-20       Impact factor: 2.931

5.  Platinum sensitive carcinoma of ovary relapsed as pericardial effusion with cardiac tamponade.

Authors:  Chinna Babu Dracham; Shipra Gupta; Chandan Krushna Das; Arun Elangovan
Journal:  BMJ Case Rep       Date:  2019-03-22

Review 6.  Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents.

Authors:  Run Yang; Changming Tan; Masoud Najafi
Journal:  Inflammopharmacology       Date:  2021-11-23       Impact factor: 4.473

7.  A case of cardiac metastases from head and neck cancer presenting as hyperdense armored heart.

Authors:  Keitaro Fujii; Takayuki Imai; Yukinori Asada; Ikuro Sato; Tomoko Yamazaki; Kazuto Matsuura
Journal:  Int Cancer Conf J       Date:  2021-09-09

8.  Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion.

Authors:  Danielle El Haddad; Cezar Iliescu; Syed Wamique Yusuf; William Nassib William; Tarif H Khair; Juhee Song; Elie N Mouhayar
Journal:  J Am Coll Cardiol       Date:  2015-09-08       Impact factor: 24.094

Review 9.  Management of Malignant Pericardial Effusion.

Authors:  Mary Petrofsky
Journal:  J Adv Pract Oncol       Date:  2014 Jul-Aug

10.  Pericardial effusion in a dog concurrent with carcinoma of unknown primary origin.

Authors:  M H Kang; J H Sur; H M Park
Journal:  Iran J Vet Res       Date:  2019       Impact factor: 1.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.